Medical Books Library for Doctors, Physicians, Surgeons, Dentists, Intensivists, Physician Assistants, Nurses, Medical Technicians and Medical Students
Medical books library
This book focuses on major trends and challenges in the detection of lung cancer, presenting work aimed at identifying new techniques and their use in biomedical analysis. Volume 1 examines the main applications of computer-aided diagnosis to lung cancer. It is ideal for academics, industry professionals and advanced students.
Based on DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology, Eleventh Edition, this comprehensive review book covers the entire specialty of oncology, including new or expanded coverage of molecular biology; epidemiology and etiology; screen and prevention; genetics; clinical trials; and immunotherapy. Inside, readers will discover hundreds of multiple-choice and case-based questions, along with detailed answers and explanations to help explain the how and why behind each correct response. The ideal way to maximize exam scores for today’s student and residents!
Learning and review features include:
Enrich Your eBook Reading Experience
The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer in the world. In the next 10 years, 150,000 people in the United States will die from liver disease or liver cancer associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Today, between 800,000 and 1.4 million people in the United States have chronic hepatitis B and between 2.7 and 3.9 million have chronic hepatitis C. People most at risk for hepatitis B and C often are the least likely to have access to medical services. Reducing the rates of illness and death associated with these diseases will require greater awareness and knowledge among health care workers, improved identification of at-risk people, and improved access to medical care.
Hepatitis B is a vaccine-preventable disease. Although federal public health officials recommend that all newborns, children, and at-risk adults receive the vaccine, about 46,000 new acute cases of the HBV infection emerge each year, including 1,000 in infants who acquire the infection during birth from their HBV-positive mothers. Unfortunately, there is no vaccine for hepatitis C, which is transmitted by direct exposure to infectious blood.
Hepatitis and Liver Cancer identifies missed opportunities related to the prevention and control of HBV and HCV infections. The book presents ways to reduce the numbers of new HBV and HCV infections and the morbidity and mortality related to chronic viral hepatitis. It identifies priorities for research, policy, and action geared toward federal, state, and local public health officials, stakeholder, and advocacy groups and professional organizations.
First written by Philip Stell and Arnold Maran in 1972, Stell & Maran’s Textbook of Head and Neck Surgery and Oncology has been revised in both content and approach over the years to reflect the enormous progress made in the area. Now in its fifth edition, the book remains a key textbook for trainees in otolaryngology and head and neck surgery.
Written with a strong multidisciplinary approach, the book has expanded considerably to include the expertise of international editors and contributing authors from a wide variety of backgrounds, including ENT, radiotherapy, plastic surgery, and maxillofacial surgery.
Key Features:
As a first text for trainee head and neck and ENT surgeons or as a reference source for practitioners in a variety of related fields, Stell & Maran’s Textbook of Head and Neck Surgery and Oncology remains the best-illustrated and most up-to-date volume in its field.
Print Versions of this book also include access to the ebook version.
Completely revised and updated for 2024, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens–both on- and off-label–for the treatment of all the major cancers. Key Features: – Includes 12 new agents and several new supplemental indications that have all been approved by the FDA within the past year – Updated new indications for previously approved agents – Indications, drug doses and schedules, toxicities, and special considerations for each agent expanded and revised – A specific chapter focused on antiemetic treatment regimens for both acute and delayed nausea/vomiting – Diagrams of drug structures and pathways for many of the agents – A comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages – Covers toxicity and drug-drug interactions – A section on chemotherapy regimens for all major cancers – Provides an overview of the basic principles of cancer drug therapy Your must-have Physicians’ Cancer Chemotherapy Drug Manual is available for your iPhone, iPad, and Android
The Bethesda Handbook of Clinical Oncology is a clear, concise and comprehensive reference book for the busy clinician to use in his or her daily patient encounters. It focuses less on etiology, pathophysiology, and epidemiology, and considerably more on practical clinical information. Cancer management information is presented in a reader-friendly format that offers a comprehensive review of each disease along with the most commonly used treatment regimens, including chemotherapy dosing and schedules.
Features:
Clear, concise, complete reference book for busy clinician for daily patient management
User-friendly formatting – tables, algorithms, charts, bullet points
Contributors all from NIH (or they trained there)
Great for board exams
Organized by body region
New to this edition:
Add a chapter on Cancer Genetics and expand the Basics of Genomics for practicing oncologists to include the clinically relevant molecular tests.
Major addition will be to add about 5 board review question and answers per chapter – more than 200 board review questions
New treatment regimens added to all appropriate chapters
New clinical trial data added on treatment
More chemotherapeutic agents added (including newer regimens and dosages)
Selected as a Doody’s Core Title for 2022 and 2023!
Comprehensive, authoritative, and up to date, Pizzo and Poplack’s Pediatric Oncology, 8th Edition, remains your most trusted source of information on the care and research of children with cancer. This award-winning text is the single most comprehensive reference on the biology and genetics of childhood cancer, its diagnosis and multimodal treatment, and long-term management. In the tradition of excellence established by Drs. Philip A. Pizzo and David G. Poplack, this 8th Edition keeps you fully informed while helping you collaborate more effectively with others on the cancer care team to enhance quality-of-life issues for patients and families.
Enrich Your eBook Reading Experience
“This book admirably covers prostate cancer. It is written in an easily digestible manner for non-experts and emphasizes the importance of a team approach to treatment of patients with this disease.”–Doody’s Reviews
With an emphasis on multidisciplinary collaboration and decision-making, this practical resource reflects the extraordinary advances in the treatment of prostate cancer during the past five years. Approximately thirty international, leading-edge investigators describe the most current evidence-based approaches to prostate cancer treatment. The book provides a comprehensive view of the entire spectrum of prostate cancer management from initial screening through novel and experimental treatments that have the potential for a major impact on practice.
The book first reviews fundamental issues including epidemiology, screening, risk reduction, diagnosis and pathologic characterization, staging, and imaging. This includes strategies for improving the accuracy of PSA screening and an update on controversies surrounding the ISUP Modified Gleason Score. The book covers novel molecular and genotype profiling in prostate cancer, including morphometric and systems pathology. Detailed information is provided on radiographic imaging for diagnosis and staging. The treatment sections of the book correspond to the staging of disease. The treatment of localized disease addresses the range of multidisciplinary management options including a discussion of prostate cancer’s impact on the quality of life. A detailed review of multimodal therapies (medical, surgical, and radiologic) addresses the treatment of localized advanced disease, and coverage of advanced metastatic prostate cancer reviews current management options including a range of promising novel and experimental agents. The book also discusses counseling the high-risk patient. Several chapters incorporate models of care delivery, patient navigation for multidisciplinary care, genomic and risk assessment, and comparative effects of research in treatment decision-making. The book is designed as a management text for all health care professionals who provide care for prostate cancer patients as well as patients, families, and advocates. Extensive references offer opportunities for additional study.
Key Features:
